Antibody Specificity

Vaccines and Antiviral Agents
Differential Specificity and Immunogenicity of Adenovirus Type 5 Neutralizing Antibodies Elicited by Natural Infection or Immunization
Cheng Cheng, Jason G. D. Gall, Martha Nason, C. Richter King, Richard A. Koup, Mario Roederer, M. Juliana McElrath, Cecilia A. Morgan, Gavin Churchyard, Lindsey R. Baden, Ann C. Duerr, Michael C. Keefer, Barney S. Graham, Gary J. Nabel
Pathogenesis and Immunity
Antibody Specificities Associated with Neutralization Breadth in Plasma from Human Immunodeficiency Virus Type 1 Subtype C-Infected Blood Donors
Elin S. Gray, Natasha Taylor, Diane Wycuff, Penny L. Moore, Georgia D. Tomaras, Constantinos Kurt Wibmer, Adrian Puren, Allan DeCamp, Peter B. Gilbert, Blake Wood, David C. Montefiori, James M. Binley, George M. Shaw, Barton F. Haynes, John R. Mascola, Lynn Morris
Virus-Cell Interactions
Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies
Joe Grove, Søren Nielsen, Jin Zhong, Margaret F. Bassendine, Heidi E. Drummer, Peter Balfe, Jane A. McKeating
Pathogenesis and Immunity
Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C
James M. Binley, Elizabeth A. Lybarger, Emma T. Crooks, Michael S. Seaman, Elin Gray, Katie L. Davis, Julie M. Decker, Diane Wycuff, Linda Harris, Natalie Hawkins, Blake Wood, Cory Nathe, Douglas Richman, Georgia D. Tomaras, Frederic Bibollet-Ruche, James E. Robinson, Lynn Morris, George M. Shaw, David C. Montefiori, John R. Mascola
Pathogenesis and Immunity | Spotlight
The C3-V4 Region Is a Major Target of Autologous Neutralizing Antibodies in Human Immunodeficiency Virus Type 1 Subtype C Infection
Penny L. Moore, Elin S. Gray, Isaac A. Choge, Nthabeleng Ranchobe, Koleka Mlisana, Salim S. Abdool Karim, Carolyn Williamson, Lynn Morris
and and the CAPRISA 002 Study Team
Pathogenesis and Immunity
Type-Specific Epitopes Targeted by Monoclonal Antibodies with Exceptionally Potent Neutralizing Activities for Selected Strains of Human Immunodeficiency Virus Type 1 Map to a Common Region of the V2 Domain of gp120 and Differ Only at Single Positions from the Clade B Consensus Sequence
W. J. Honnen, C. Krachmarov, S. C. Kayman, M. K. Gorny, S. Zolla-Pazner, A. Pinter
Vaccines and Antiviral Agents
Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein
Theodore Oliphant, Grant E. Nybakken, Michael Engle, Qing Xu, Christopher A. Nelson, Soila Sukupolvi-Petty, Anantha Marri, Bat-El Lachmi, Udy Olshevsky, Daved H. Fremont, Theodore C. Pierson, Michael S. Diamond
Vaccines and Antiviral Agents
Factors Determining the Breadth and Potency of Neutralization by V3-Specific Human Monoclonal Antibodies Derived from Subjects Infected with Clade A or Clade B Strains of Human Immunodeficiency Virus Type 1
C. P. Krachmarov, W. J. Honnen, S. C. Kayman, M. K. Gorny, S. Zolla-Pazner, Abraham Pinter
ERRATA
Isolation of Human Monoclonal Antibodies That Neutralize Human Rotavirus
Kyoko Higo-Moriguchi, Yasushi Akahori, Yoshitaka Iba, Yoshikazu Kurosawa, Koki Taniguchi
Vaccines and Antiviral Agents
Isolation of Human Monoclonal Antibodies That Neutralize Human Rotavirus
Kyoko Higo-Moriguchi, Yasushi Akahori, Yoshitaka Iba, Yoshikazu Kurosawa, Koki Taniguchi

Main menu

User menu

Search

Antibody Specificity

Pages